D-0898-2021 Class II Terminated
FDA drug recall D-0898-2021 was initiated by SigmaPharm Laboratories LLC on Sep 21, 2021 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications; Out of Specification impurity results obtained during routine testing. The recall status is terminated (terminated Sep 26, 2022). Affected quantity: 1192 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 6, 2021
- Initiation Date
- Sep 21, 2021
- Termination Date
- Sep 26, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1192 bottles
Product description
Sodium Phenylbutyrate Powder, 250 Grams, Rx Only, packaged in 500 cc HDPE bottles and 53 mm CRC caps packed in a carton and then in case packs containing 2 bottles. Sigmapharm Laboratories, LLC, Bensalem, PA 19020, NDC 42794-086-14
Reason for recall
Failed Impurities/Degradation Specifications; Out of Specification impurity results obtained during routine testing.
Distribution pattern
Nationwide
Code information
Lots 2005401, 2005501, 2005601, 2005701, Exp FEB 2023; Lots 2101401, 2101501, Exp FEB-2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0898-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026